ACUTAAS — Acutaas Chemicals Income Statement
0.000.00%
- IN₹134.83bn
- IN₹132.58bn
- IN₹10.07bn
Annual income statement for Acutaas Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,362 | 5,201 | 6,167 | 7,175 | 10,069 |
| Cost of Revenue | |||||
| Gross Profit | 1,545 | 2,445 | 2,812 | 3,012 | 4,182 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,641 | 4,250 | 5,057 | 6,371 | 8,014 |
| Operating Profit | 721 | 951 | 1,110 | 804 | 2,055 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 717 | 915 | 1,122 | 819 | 2,162 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 540 | 719 | 833 | 487 | 1,604 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 540 | 719 | 833 | 428 | 1,587 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 540 | 719 | 833 | 428 | 1,587 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.39 | 10.5 | 11.5 | 8.42 | 19.8 |
| Dividends per Share |